Search company, investor...
Vision RT company logo

Vision RT

visionrt.com

Founded Year

2001

Stage

Unattributed VC | Alive

Total Raised

$380K

Last Raised

$380K | 16 yrs ago

About Vision RT

Vision RT is setting a new standard of care in motion management. The company provides superior solutions for the radiotherapy market, with products installed in some of the largest treatment centers in the world.

Headquarters Location

Dove House Arcadia Avenue

London, England, N32JU,

United Kingdom

+44-20-83464300

Missing: Vision RT's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vision RT's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Vision RT

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vision RT is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Vision RT Patents

Vision RT has filed 40 patents.

The 3 most popular patent topics include:

  • Radiation therapy
  • Medical physics
  • Radiobiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/17/2019

3/28/2023

Radiation therapy, Medical physics, Sheep breeds, Medical imaging, Digital photography

Grant

Application Date

4/17/2019

Grant Date

3/28/2023

Title

Related Topics

Radiation therapy, Medical physics, Sheep breeds, Medical imaging, Digital photography

Status

Grant

Latest Vision RT News

U.S. hospital applies biometric facial recognition to cancer treatment verification after FDA approval

Jul 1, 2019

Jul 1, 2019 Parker Adventist Hospital in Colorado is using biometric facial recognition from Vision RT to confirm the identity and treatment of cancer patients after it was approved by the FDA in June, making it the first hospital to apply the technology for the specific use case, according to local Fox affiliate KDVR . Patients faces are scanned with Vision RT’s SafeRT-ID to remove human error from the process, and consistently verify the correct treatment for a specific patient. Providing verification with a non-contact procedure is important for people with compromised immune systems, according to the report. The system also provides additional information to help patients prepare for treatment. Parker Adventist is a Centura Health Facility, one of roughly a half-dozen hospitals and other health care facilities making up a network in Kansas and Colorado. The global market for healthcare biometrics is forecasted by Grand View Research to reach $14.5 billion by 2025 . Vision RT acquired facial recognition provider Aurora in April, picking up the UK company’s AI expertise.

Vision RT Frequently Asked Questions (FAQ)

  • When was Vision RT founded?

    Vision RT was founded in 2001.

  • Where is Vision RT's headquarters?

    Vision RT's headquarters is located at Dove House, London.

  • What is Vision RT's latest funding round?

    Vision RT's latest funding round is Unattributed VC.

  • How much did Vision RT raise?

    Vision RT raised a total of $380K.

  • Who are the investors of Vision RT?

    Investors of Vision RT include The Capital Fund and YFM Equity Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.